study	group	count	intervention	measurement_type	substance	tissue	method	time	time_unit	mean	median	min	max	sd	se	cv	unit	comments
Lee2012	group1	22	GLI2	cmax	glimepiride	plasma	HPLC MS/MS	NA	NA	218.5	NA	187.4	249.7	NA	NA	NA	ng/ml	NA
Lee2012	group1	22	GLI2	tmax	glimepiride	plasma	HPLC MS/MS	NA	NA	2.8	NA	2.5	3.1	NA	NA	NA	hr	NA
Lee2012	group1	22	GLI2	thalf	glimepiride	plasma	HPLC MS/MS	NA	NA	2.9	NA	2.6	3.2	NA	NA	NA	hr	NA
Lee2012	group1	22	GLI2	oral-clearance	glimepiride	plasma	HPLC MS/MS	NA	NA	2547.5	NA	2095.0	3000.0	NA	NA	NA	ml/hr	NA
Lee2012	group1	22	GLI2	auc_end	glimepiride	plasma	HPLC MS/MS	12.0	hr	843.0	NA	703.6	982.5	NA	NA	NA	ng*hr/ml	NA
Lee2012	group1	22	GLI2	auc_inf	glimepiride	plasma	HPLC MS/MS	NA	NA	892.7	NA	742.0	1043.4	NA	NA	NA	ng*hr/ml	NA
